Palliative Viszeralchirurgie

Maximilian von Heesen; Michael Ghadimi

doi:10.1055/a-1438-2238

Allgemein- und Viszeralchirurgie up2date, Table of Contents

Allgemein- und Viszeralchirurgie up2date 2021; 15(05): 383-402
DOI: 10.1055/a-1438-2238

Allgemeine Chirurgie

Palliative Viszeralchirurgie

Authors

Maximilian von Heesen
Michael Ghadimi

Abstract

All articles of this category

In der palliativen Behandlung steht die Linderung von Schmerzen, Atemnot, Übelkeit und anderen Krankheitsbeschwerden, die am Lebensende und bei unheilbaren Erkrankungen auftreten, im Vordergrund. Die Therapie dieser Beschwerden und Notfallsituationen ist immer individuell und abhängig von der jeweiligen Erkrankungssituation und dem Patientenwillen. Im vorliegenden Artikel befassen wir uns mit den Besonderheiten der Behandlung von palliativen Patienten im perioperativen Verlauf und bei den häufigsten Komplikationen.

Schlüsselwörter

Palliativmedizin - palliative Viszeralchirurgie - gastrointestinale Passagestörung - Blutung - Hohlorganperforation - Lebensqualität - Schmerztherapie

Full Text

References

Literatur
1 de Rosa N, Blazer III D. Quality of life assessment in palliative surgery. J Palliative Care Med 2013; S2: 5
2 Zimmermann C, Swami N, Krzyzanowska M. et al. Early palliative care for patients with advanced cancer: a cluster-randomised controlled trial. Lancet 2014; 383: 1721-1730
3 Gärtner J, Wedding U, Alt-Epping B. Frühzeitige spezialisierte palliativmedizinische Mitbehandlung. Onkologe 2015; 21: 1182-1188
4 Dantzer R. Cytokine-induced sickness behavior: mechanisms and implications. Ann N Y Acad Sci 2001; 933: 222-234
5 Bang A, Schoenfeld JD. Immunotherapy and radiotherapy for metastatic cancers. Ann Palliat Med 2019; 8: 312-325
6 Deshaies I, Malka D, Soria J-C. et al. Antiangiogenetic agents and late anastomotic complications. J Surg Oncol 2010; 101: 180-183
7 Adam AB, Ozdamar MY, Esen HH. et al. Local effects of epidermal growth factor on the wound healing in esophageal anastomosis: an experimental study. Int J Pediatr Otorhinolaryngol 2017; 99: 8-12
8 Bateni SB, Meyers FJ, Bold RJ. et al. Increased rates of prolonged length of stay, readmissions, and discharge to care facilities among postoperative patients with disseminated malignancy: implications for clinical practice. PLoS One 2016; 11: e0165315
9 Tohme S, Simmons RL, Tsung A. Surgery for cancer: a trigger for metastases. Cancer Res 2017; 77: 1548-1552
10 Torrance HD, Brohi K, Pearse RM. et al. Association between gene expression biomarkers of immunosuppression and blood transfusion in severely injured polytrauma patients. Ann Surg 2015; 261: 751-759
11 To TH, To LB, Currow DC. Can we detect transfusion benefits in palliative care patients?. J Palliat Med 2016; 19: 1110-1113
12 Bulla SC, Badil PR, Silva RC. et al. Platelets inhibit migration of canine osteosarcoma cells. J Comp Pathol 2017; 156: 3-13
13 Schmidt BL. The neurobiology of cancer pain. Neuroscientist 2014; 20: 546-562
14 Chen EP, Smith EM. COX-2 and PGE2-dependent immunomodulation in breast cancer. Prostaglandins Other Lipid Mediat 2011; 96: 14-20
15 Brack A. Anästhesie in der Viszeralchirurgie. In: Rossaint R, Werner C, Zwißler B. Hrsg. Die Anästhesiologie. 3. Aufl.. Heidelberg: Springer; 2012: 1013-1032
16 Druml C, Ballmer PE, Druml W. et al. ESPEN guideline on ethical aspects of artificial nutrition and hydration. Clin Nutr 2016; 35: 545-556
17 McCaughan H, Boyle S, McGoran JJ. Update on the management of the gastrointestinal effects of radiation. World J Gastrointest Oncol 2021; 13: 400-408
18 Weimann A, Braga M, Carli F. et al. ESPEN guideline: Clinical nutrition in surgery. Clin Nutr 2017; 36: 623-650
19 Chi DS, Phaëton R, Miner TJ. et al. A prospective outcomes analysis of palliative procedures performed for malignant intestinal obstruction due to recurrent ovarian cancer. Oncologist 2009; 14: 835-839
20 Teixeira PG, Karamanos E, Talving P. et al. Early operation is associated with a survival benefit for patients with adhesive bowel obstruction. Ann Surg 2013; 258: 459-465
21 Ripamonti CI, Easson AM, Gerdes H. Management of malignant bowel obstruction. Eur J Cancer 2008; 44: 1105-1115
22 Laval G, Marcelin-Benazech B, Guirimand F. et al. Recommendations for bowel obstruction with peritoneal carcinomatosis. J Pain Symptom Manag 2014; 48: 75-91
23 Branco BC, Barmparas G, Schnüriger B. et al. Systematic review and meta-analysis of the diagnostic and therapeutic role of water-soluble contrast agent in adhesive small bowel obstruction. D. Br J Surg 2010; 97: 470-478
24 Spaander MC, Baron TH, Siersema PD. et al. Esophageal stenting for benign and malignant disease: European Society of Gastrointestinal Endoscopy (ESGE) Clinical Guidline. Endoscopy 2016; 48: 939-948
25 Ojima T, Nakamori M, Nakamura M. et al. Laparoscopic gastrojejunostomy for patients with unresectable gastric cancer with gastric outlet obstruction. J Gastrointest Surg 2017; 21: 1220-1225
26 Schweigert M. Interventionelle Versorgung tracheo-/bronchoösophagealer Fisteln. Chirurg 2019; 90: 710-721
27 Troncone E, Fugazza A, Cappello A. et al. Management of malignant gastric outlet obstruction. World J Gastroenterol 2020; 26: 1847-1860
28 Jeurnink SM, Steyerberg EW, van Hooft JE. et al. Dutch SUSTENT Study Group. Surgical gastrojejunostomy or endoscopic stent placement for the palliation of malignant gastric outlet obstruction (SUSTENT study): a multicenter randomized trial. Gastrointest Endosc 2010; 71: 490-499
29 Horstmann O, Kley CW, Post S. et al. Cross section gastroenterostomy in patients with irresectable periampullary carcinoma. HPB (Oxford) 2001; 3: 157-163
30 Fujitani K, Ando M, Sakamakiet K. et al. A prospective multicenter observational study of surgical palliation examining postoperative quality of life in patients treated for malignant gastric outlet obstruction caused by incurable advanced gastric cancer. J Clin Oncol 2017; 35 (4 Suppl): 6
31 Perone JA, Riall TS, Olino K. Palliative care for pancreatic and periampullary cancer. Surg Clin North Am 2016; 96: 1415-1430
32 Miner TJ, Cohen J, Charpentier K. et al. The palliative triangle: Improved patient selection. Arch Surg 2011; 146: 517-522
33 Blakely AM, Heffernan DS, McPhillips J. et al. Elevated c-reactive protein as a predictor of patient outcomes following palliative surgery. J Surg Oncol 2014; 110: 651-655
34 Cousins SE, Tempest E, Feuer DJ. et al. Surgery for the resolution of symptoms in malignant bowel obstruction in advanced gynaecological and gastrointestinal cancer. Cochrane Database Syst Rev 2016; (01) CD002764
35 Bassi N, Caratozzolo E, Bonariol L. et al. Management of ruptured hepatocellular carcinoma: Implications for therapy. World J Gastroenterol 2010; 16: 1221-1225
36 Mochimoru T, Minematsu N, Ohsawa K. et al. Hemoperitoneum secondary to rupture of a hepatic metastasis from small cell lung cancer during chemotherapy: a case with a literature review. Intern Med 2017; 56: 695-699
37 Rogalski P, Daniluk J, Baniukiewicz A. et al. Endoscopic management of gastrointestinal perorations, leaks and fistulas. World J Gastroenterol 2015; 21: 10542-10552
38 Paspatis GA, Dumonceau JM, Barthet M. et al. Diagnosis and management of iatrogenic endoscopic perforations: European Society of Gastrointestinal Endoscopy (ESGE) Position Statement. Endoscopy 2014; 46: 693-711
39 Schmidt A, Fuchs KH, Caca K. et al. The endoscopic treatment of iatrogenic gastrointestinal perforation. Dtsch Arztebl Int 2016; 113: 121-128
40 Cauley CE, Panizales MT, Reznor G. et al. Outcomes after emergency abdominal surgery in patients with advanced cancer: opportunities to reduce complications and improve palliative care. J Trauma Acute Care Surg 2015; 79: 399-406
41 Brangewitz M, Voigtländer T, Helfritz FA. et al. Endoscopic closure of esophageal intrathoracic leaks: stent versus endoscopic vacuum-assisted closure, a retrospective analysis. Endoscopy 2013; 45: 433-438
42 Cho SB, Lee WS, Joo YE. et al. Therapeutic options for iatrogenic colon perforation: feasibility of endoscopic clip closure and predictors of the need for early surgery. Surg Endosc 2012; 26: 473-479